About the Holding company

CMIC Ashfield is the result of a joint initiative by CMIC Holdings Plc. and Ashfield Engage, part of Inizio. two major healthcare organizations providing a full breadth of capabilities on an international basis.

About CMIC Holdings Co., Ltd.

CMIC Group pioneered the CRO business in Japan over 28 years ago. Since then CMIC has continued as a leading innovator in the industry and has expanded services to encompass the entire pharmaceutical value-chain. We pride ourselves on meeting customers where they are and with exactly what they need to move their products forward.

CMIC offers tailored solutions for pharmaceutical companies, medical device manufacturers, academia, bio-ventures and medical institutions. Using our collective strengths, we offer a broad range of services from preclinical research to practical applications.

For more information, go to

About CMIC Holdings Co., Ltd.

About Ashfield Engage

Ashfield Engage, part of Inizio, is an expert, global partner in customer strategy and execution. Ashfield Engage helps clients connect with all healthcare audiences to ensure people get knowledge, support and medicines when and where they need them. As experts in strategic engagement, Ashfield Engage creates personalized, impactful experiences, across all channels. Every program is underpinned by human connections, omnichannel engagement and adaptive analytics.
Ashfield Engage has over 20 years’ experience with a team of over 5,000 employees, delivering services in more than 50 countries. Offering services across Medical Affairs, Market Access, Commercial, Patient Solutions and Event Experiences, Ashfield Engage helps its clients to engage with their stakeholders across the whole commercialization journey. 

For more information, go to


About Inizio

Uniting the expertise and capabilities of Ashfield and Huntsworth, Inizio is a strategic partner for companies in health and life sciences. Connecting a full suite of advisory, medical, marketing, communications and patient and stakeholder engagement services across the lifecycle of a drug, Inizio supports its partners from initial assessment to loss of exclusivity.
Inizio has five specialist business units, each comprising of best-in-class companies that provide the depth, breadth and scale to activate transformational change and reimagine health.
Inizio is backed by Clayton, Dubilier & Rice (CD&R). 

For more information, go to



Together, across both Ashfield Engage and CMIC, we are based in 30 countries and provide services in over 50 countries and areas.




History of CSO business in the CMIC Group
UDG and Ashfield


CMIC Co. Ltd. is established


CMIC becomes Japan’s first CRO
(Contract Research Organization)


Ashfield Healthcare is established


CMIC establishes CMIC-CIM Co. Ltd. to train and develop MR and provide marketing support to Pharmaceutical Companies

Ashfield joins the United Drug group


CMIC-CIM changes its denomination to


With the acquisition of In2Focus, the new company Ashfield In2Focus becomes UK’s No.1 CSO

CMIC Group launched CSO services


CMIC-MPSS starts providing PMS monitoring services


SFE business is reinforced

CMIC-MPSS starts providing PMS monitoring services


Healthcare communications services are launched


Merges with Pharmexx (German CSO)

The SFE services are launched

CMIC Holdings and UDG Healthcare sign CSO business collaboration agreement


Trade name is changed with formation of a joint venture by CMIC Holdings and UDG Healthcare
MPSS and Ashfield officially launch the CMIC Ashfield joint venture


The Medical Affairs services are launched
PMS Monitoring services are transferred to CMIC PMS
The Contact Center services are launched